Mitochondria in health, disease, and aging

JS Harrington, SW Ryter, M Plataki… - Physiological …, 2023 - journals.physiology.org
Mitochondria are well known as organelles responsible for the maintenance of cellular
bioenergetics through the production of ATP. Although oxidative phosphorylation may be …

[HTML][HTML] Magnetic iron oxide nanoparticles for brain imaging and drug delivery

R Qiao, C Fu, H Forgham, I Javed, X Huang… - Advanced Drug Delivery …, 2023 - Elsevier
Central nervous system (CNS) disorders affect as many as 1.5 billion people globally. The
limited delivery of most imaging and therapeutic agents into the brain is a major challenge …

Therapeutic inhibition of ferroptosis in neurodegenerative disease

SK Ryan, CL Ugalde, AS Rolland, J Skidmore… - Trends in …, 2023 - cell.com
Iron accumulation has been associated with the etiology and progression of multiple
neurodegenerative diseases (NDDs). The exact role of iron in these diseases is not fully …

[HTML][HTML] Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease

J Nowell, E Blunt, D Gupta, P Edison - Ageing Research Reviews, 2023 - Elsevier
Therapeutic strategies for neurodegenerative disorders have commonly targeted individual
aspects of the disease pathogenesis to little success. Neurodegenerative diseases …

Is Alzheimer disease a disease?

AD Korczyn, LT Grinberg - Nature Reviews Neurology, 2024 - nature.com
Dementia, a prevalent condition among older individuals, has profound societal
implications. Extensive research has resulted in no cure for what is perceived as the most …

Immune Activation in Alzheimer Disease

A Mary, R Mancuso, MT Heneka - Annual Review of …, 2024 - annualreviews.org
Alzheimer disease (AD) is the most common neurodegenerative disease, and with no
efficient curative treatment available, its medical, social, and economic burdens are …

The reverse transcriptase inhibitor 3TC protects against age‐related cognitive dysfunction

D Wahl, ME Smith, CM McEntee, AN Cavalier… - Aging …, 2023 - Wiley Online Library
Aging is the primary risk factor for most neurodegenerative diseases, including Alzheimer's
disease. Major hallmarks of brain aging include neuroinflammation/immune activation and …

Alzheimer's disease-related epigenetic changes: novel therapeutic targets

A Paniri, MM Hosseini, H Akhavan-Niaki - Molecular Neurobiology, 2024 - Springer
Aging is a significant risk factor for Alzheimer's disease (AD), although the precise
mechanism and molecular basis of AD are not yet fully understood. Epigenetic mechanisms …

[HTML][HTML] The importance of complement-mediated immune signaling in Alzheimer's disease pathogenesis

AF Batista, KA Khan, MT Papavergi… - International Journal of …, 2024 - mdpi.com
As an essential component of our innate immune system, the complement system is
responsible for our defense against pathogens. The complement cascade has complex …

[HTML][HTML] Complexity of sex differences and their impact on Alzheimer's disease

M Kadlecova, K Freude, H Haukedal - Biomedicines, 2023 - mdpi.com
Sex differences are present in brain morphology, sex hormones, aging processes and
immune responses. These differences need to be considered for proper modelling of …